Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Insights and Forecast to 2028

Table Of Contents

1 Study Coverage

1.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Introduction 1.2 Market by Type 1.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Serotype 6B 1.2.3 7F Serotype 1.2.4 Serotype 9V 1.2.5 14 Serotype 1.2.6 Serotype 18C 1.2.7 Serotype 19A 1.2.8 19F Serotype 1.2.9 23F Serotype 1.2.10 24F Serotype 1.2.11 Other 1.3 Market by Application 1.3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Infants from 6 Weeks to 15 Months Old 1.3.3 Children Aged 15 Months to 5 Years 1.4 Study Objectives 1.5 Years Considered2 Executive Summary 2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Estimates and Forecasts 2017-2028 2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Estimates and Forecasts 2017-2028 2.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region 2.4.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region (2017-2022) 2.4.2 Global Sales 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Region (2023-2028) 2.5 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region 2.5.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region (2017-2022) 2.5.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa3 Competition by Manufacturers 3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Manufacturers 3.1.1 Global Top 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturers by Sales (2017-2022) 3.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) in 2021 3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Manufacturers 3.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Manufacturers (2017-2022) 3.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue in 2021 3.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans4 Market Size by Type 4.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type 4.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Historical Sales by Type (2017-2022) 4.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Forecasted Sales by Type (2023-2028) 4.1.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2017-2028) 4.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Type 4.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Historical Revenue by Type (2017-2022) 4.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Forecasted Revenue by Type (2023-2028) 4.2.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Type (2017-2028) 4.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Type 4.3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Type (2017-2022) 4.3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price Forecast by Type (2023-2028)5 Market Size by Application 5.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application 5.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Historical Sales by Application (2017-2022) 5.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Forecasted Sales by Application (2023-2028) 5.1.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2017-2028) 5.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Application 5.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Historical Revenue by Application (2017-2022) 5.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Forecasted Revenue by Application (2023-2028) 5.2.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Application (2017-2028) 5.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Application 5.3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Application (2017-2022) 5.3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price Forecast by Application (2023-2028)6 North America 6.1 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Type 6.1.1 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2017-2028) 6.1.2 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Type (2017-2028) 6.2 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Application 6.2.1 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2017-2028) 6.2.2 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Application (2017-2028) 6.3 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Country 6.3.1 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2017-2028) 6.3.2 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2017-2028) 6.3.3 United States 6.3.4 Canada7 Europe 7.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Type 7.1.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2017-2028) 7.1.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Type (2017-2028) 7.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Application 7.2.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2017-2028) 7.2.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Application (2017-2028) 7.3 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Country 7.3.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2017-2028) 7.3.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia8 Asia Pacific 8.1 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Type 8.1.1 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2017-2028) 8.1.2 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Type (2017-2028) 8.2 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Application 8.2.1 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2017-2028) 8.2.2 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Application (2017-2028) 8.3 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Region 8.3.1 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region (2017-2028) 8.3.2 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 China Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia9 Latin America 9.1 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Type 9.1.1 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2017-2028) 9.1.2 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Type (2017-2028) 9.2 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Application 9.2.1 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2017-2028) 9.2.2 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Application (2017-2028) 9.3 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Country 9.3.1 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2017-2028) 9.3.2 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina10 Middle East and Africa 10.1 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Type 10.1.1 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2017-2028) 10.1.2 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Type (2017-2028) 10.2 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Application 10.2.1 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2017-2028) 10.2.2 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Application (2017-2028) 10.3 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Country 10.3.1 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2017-2028) 10.3.2 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia11 Company Profiles 11.1 Pfizer 11.1.1 Pfizer Corporation Information 11.1.2 Pfizer Overview 11.1.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Pfizer Recent Developments 11.2 Minhai Bio 11.2.1 Minhai Bio Corporation Information 11.2.2 Minhai Bio Overview 11.2.3 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Minhai Bio Recent Developments 11.3 Kexing Bio 11.3.1 Kexing Bio Corporation Information 11.3.2 Kexing Bio Overview 11.3.3 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Kexing Bio Recent Developments 11.4 Cansino Bio 11.4.1 Cansino Bio Corporation Information 11.4.2 Cansino Bio Overview 11.4.3 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Cansino Bio Recent Developments 11.5 Lanzhou Biological Preparations Institute 11.5.1 Lanzhou Biological Preparations Institute Corporation Information 11.5.2 Lanzhou Biological Preparations Institute Overview 11.5.3 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Lanzhou Biological Preparations Institute Recent Developments12 Industry Chain and Sales Channels Analysis 12.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industry Chain Analysis 12.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Mode & Process 12.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Marketing 12.4.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Channels 12.4.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Distributors 12.5 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Customers13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industry Trends 13.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Drivers 13.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Challenges 13.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Restraints14 Key Findings in The Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Study15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer